Thursday, 13/08/2020 16:01

IMP: BOD resolution No.38 _ 11 Aug 2020

The Board resolution No.38 dated August 11, 2020, the BOD of Imexpharm Corporation (IMP) approved the following issues:

1)      Approving the business result in first six months of 2020:

-          Total revenue & other:            597.3 billion dongs

-          Net revenue:                            592.4 billion dongs

-          Profit before tax:                     110.7 billion dongs

-          Profit after tax:                           88.4 billion dongs.

2)      Approving the business plan in last six months of 2020:

No.

Content

2020 (F)

% plan in 2020

2019

% Growth

1

Total revenue & other

1,575.0

90.0%

1,420.7

10.9%

2

Profit before tax and to distribute Science & Technology Development Fund

260.0

 

222.4

16.9%

3

Profit before tax

260.0

100%

202.4

28.5%

 

3)      Approving the establishment of Functional Food Factory and Resting Center at No.04 Street 30/4, ward 1, Cao Lanh City, Dong Thap Province.

HOSE

Other News

>   VTB: Board resolution on the extension of the term of CEO (13/08/2020)

>   PXT: PXT still in the supervision status (13/08/2020)

>   L10: Board resolution on credit limit in 2020 (13/08/2020)

>   NPM11805: NPM11805 signs an Auditing Contract (13/08/2020)

>   NPM11911: NPM11911 signs an Auditing Contract (13/08/2020)

>   NPM11910: NPM11910 signs an Auditing Contract (13/08/2020)

>   NPM11909: NPM11909 signs an Auditing Contract (13/08/2020)

>   NPM11907: NPM11907 signs an Auditing Contract (13/08/2020)

>   HTT: HNX notice: Additional reason for putting stock under trading restriction (13/08/2020)

>   HLA: HNX notice: Additional reason for putting stock under trading restriction (13/08/2020)

Online Services
iDragon
Place Order

Là giải pháp giao dịch chứng khoán với nhiều tính năng ưu việt và tinh xảo trên nền công nghệ kỹ thuật cao; giao diện thân thiện, dễ sử dụng trên các thiết bị có kết nối Internet...
User manual
Updated version